Regeneron Antibody Cocktail Proved Effective Against COVID-19
More good news from BCW member Regeneron Pharmaceuticals which this week released a new analysis of data showing that its monoclonal antibody cocktail known as REGEN-COV is effective against Covid-19 infection.
Positive results from a Phase 3 trial jointly run with the National Institute of Allergy and Infectious Diseases showed that the drug reduces by 81.6% the risk of being infected by the Covid-19 virus, SARS-CoV-2. The data are from an ongoing clinical trial in which a group of participants received a 1,200-milligram dose of the drug in four injections administered under the skin.
The clinical trial involved 1,683 people who were tested to be sure they were not infected with Covid and did not have antibodies for the virus. Participants in the trial received either the Regeneron drug or a placebo. It was a double-blind study that initially kept secret the identities of participants who received the monoclonal antibodies and those who did not.
“Today’s new data demonstrate how a single dose of REGEN-COV can help protect people from Covid-19 for many months after administration,” said Myron S. Cohen, a doctor who leads the monoclonal antibody efforts for the Covid Prevention Network, which is sponsored by the National Institutes of Health.
George D. Yancopoulos, President and Chief Scientific Officer at Regeneron, said, “These data add to the increasing body of evidence supporting use of REGEN-COV to prevent Covid-19 in uninfected individuals, which may be especially useful for the many immunocompromised people who do not respond adequately to vaccines. With infections still occurring despite widespread vaccination, the immunocompromised face an ongoing risk of encountering the virus during their daily lives.”
Yancopoulos and Regeneron CEO Leonard Schleifer were awarded the BCW’s 2021 Global Leadership Laureate at last month’s Annual Dinner for their innovation, their development of the REGEN-COV therapy for post-exposure prevention of Covid-19, and for the company’s multi-billion-dollar investments in Westchester County.
Similar News Items
Westchester Magazine recently featured the work of the Clean Energy Action Coalition’s (CEAC) Workforce Working Group in an article that explores the burgeoning field of clean energy workforce training and local initiatives that prepare residents for high-demand “green-collar” careers. The article emphasizes that as New York State pushes toward ambitious climate goals, the need for […]
BCW Member Wartburg, a senior care and housing provider in Mount Vernon, announced this week that ArchCare, the continuing care system of the Archdiocese of New York, have entered into an agreement to integrate the operations of Wartburg’s multi-facility healthcare and senior living campus into ArchCare. Under the agreement, which is subject to regulatory and […]
In a unique partnership to expand affordable access to nursing education, BCW Members Monroe University of New Rochelle and Richmond Community Services of Mount Kisco have announced a new workforce development partnership to create an innovative, accelerated pathway for Richmond employees to earn their Licensed Practical Nurse (LPN) credentials in just one year. The program […]
Become A Member
Join the county’s largest and most influential business organization today.
JOIN NOW!
Leave a Comment
You must be logged in to post a comment.